Share

MUQUABIS: Multiscale quantum bio-imaging and spectroscopy - HORIZON-CL4-2021

Project objectives

 The main objective of MUQUABIS is to develop synergistic quantum bio-sensing and bio-imaging tools based on novel concepts for quantum frequency and infrared laser scanning and diamond-based magnetic microscopy. The combination of these tools will advance the current understanding of the molecular biological mechanisms and intracellular spatio-temporal dynamics leading to cardiac arrhythmias. Our ambition is to provide a novel conceptual and technological framework that overcomes the limitations of the state-of-the-art for cardiac imaging and spectroscopy, currently operated by classical optical and electrophysiological techniques, in terms of non-invasiveness, sensitivity, spatial and temporal resolution. MUQUABIS studies both fundamental and applied physics with the determination to ultimately lead to a roadmap for the industrialization of devices that will set the pace for a new generation of compact, non-invasive, quantum-based diagnostic and treatment tools.

The central goal of MUQUABIS is to develop synergetic tools of quantum-bio-sensing and bio-imaging, based on new concepts for quantum frequency combs and infrared lasers, and diamond-based magnetic microscopy. The combination of these tools will advance the current understanding of molecular biology mechanisms and intracellular spatio-temporal dynamics leading to cardiac arrhythmias. Our ambition is to provide a novel conceptual and technological framework that overcomes the limitations of state-of-the-art tools for cardiac imaging and spectroscopy, currently operating with classical light and electrophysiology techniques, in terms of non-invasiveness, sensitivity, spatial and temporal resolutions. MUQUABIS targets both fundamental and applied physics with the determination to lead, as ultimate outcome, to a plan for industrialization of devices, which will pave the way for a new-generation of compact and non-invasive quantum-based instrumentation for diagnostics and treatments.

Start and end date

06 / 2022 - 05 / 2027

Project Manager

Simonetta Filippi, WP Leader

Coordinating institution of the project

National Research Council - CNR

Other Institutions involved

Max-Planck-Gesellschaft zur Forderung der Wissenshaft EV - MPG
Johannes Gutenmberg - Universität Mainz
The Hebrew University of Jerusalem
Università Campus Bio-Medico di Roma
Fakultni Nemocnice SV. Anny V Brne - ICRC Brno
Leonardo SpA
Qlibri GmbH
ppqSense Srl

Funding source(s).

The MUQUABIS Project is funded by the European Union's "Horizon Europe" research and innovation program under Grant Agreement 101070546.

LINK TO THE PROJECT SITE

MUQUABIS

 

 

magnifiercrossmenuchevron-downchevron-leftchevron-right